Roslaren F 10

About

Roslaren F 10 is a combination lipid-modifying medication containing Rosuvastatin 10mg and Fenofibrate. Rosuvastatin is an HMG-CoA reductase inhibitor (statin) that primarily lowers LDL-cholesterol by inhibiting cholesterol synthesis in the liver and increasing the uptake of LDL by liver cells. Fenofibrate is a fibric acid derivative that primarily lowers triglycerides and increases HDL-cholesterol by activating peroxisome proliferator-activated receptor alpha (PPARα). This combination therapy is indicated for patients with mixed dyslipidemia who require reduction in both elevated triglycerides and LDL-cholesterol, and an increase in HDL-cholesterol, when monotherapy is insufficient.

It helps to reduce the risk of cardiovascular events associated with abnormal lipid profiles, offering a comprehensive approach to managing complex lipid disorders. Regular monitoring of lipid levels, liver function, and muscle symptoms is crucial during treatment to ensure efficacy and safety. This combination is particularly useful for patients with high triglycerides and high LDL-C who have not achieved target levels with a single agent.

Uses

• Treatment of mixed dyslipidemia
• Reduction of elevated LDL-C, total-C, and triglycerides
• Increase in HDL-C levels
• Prevention of cardiovascular events in high-risk patients

Directions For Use

Take orally once daily with food. Swallow the tablet whole; do not crush or chew. Follow your doctor's instructions carefully.

Benefits

• Comprehensive lipid profile improvement
• Significant reduction in LDL-C and triglycerides
• Effective increase in beneficial HDL-C
• Reduces overall cardiovascular risk
• Convenient single-pill combination therapy
• Suitable for patients with complex dyslipidemia

Side Effects

• Muscle pain (myalgia)
• Headache
• Nausea
• Abdominal pain
• Constipation
• Diarrhea
• Elevated liver enzymes
• Pancreatitis (rare)
• Rhabdomyolysis (rare, severe muscle breakdown)
• Gallstones (with fenofibrate)
• Fatigue
• Dizziness

Safety Measures

• Alcohol - Excessive alcohol consumption can increase the risk of liver problems and muscle side effects associated with statins and fibrates. Limit intake.
• Pregnancy - Contraindicated during pregnancy due to potential fetal harm. Discontinue immediately if pregnancy is detected.
• Breastfeeding - Contraindicated during breastfeeding as components may pass into breast milk and potentially harm the infant.
• Liver - Contraindicated in patients with active liver disease or unexplained persistent elevations of serum transaminases. Regular liver function tests are essential.
• Kidney - Use with caution and at reduced doses in patients with moderate to severe renal impairment. Monitor kidney function closely.
• Lung - Generally safe for use in patients with lung conditions. No specific contraindications related to pulmonary function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.